molluscum%20contagiosum
MOLLUSCUM CONTAGIOSUM
Molluscum contagiosum is an infection due to poxvirus that results into discrete skin lesions with central umbilication.
Spread is by skin-to-skin contact, fomites spread and autoinoculation.
Patients with atopic dermatitis, HIV or immunodeficiency are particularly susceptible.
Incubation period may be from 2-7 weeks.
In children, it usually presents with lesions on the face, scalp, ears, trunk and extremities and crural folds while in adults, it is typically sexually transmitted and affects the groin, genital area, thighs and lower abdomen.

Molluscum Contagiosum Drug Information

Drug Information

Indication: External genital & perianal warts. Actinic keratoses. Superficial basal cell carcinoma.

Indication: Active duodenal, benign gastric, stomal & recurrent ulceration, persistent dyspeptic symptoms w/ or w/o ul...

Duofilm
lactic acid + salicylic acid

Indication: Warts, corns & calluses.

Indication: Acne vulgaris.

Indication: Duodenal & gastric ulcer, GERD (including heartburn & peptic oesophagitis), persistent dyspepsia &...

T3 Acne Body Spray
allantoin + salicylic acid + triclosan

Indication: Reduces acne & pimple spots on back, chest, neck & arms.

Verrumal
dimethylsulfoxide + fluorouracil + salicylic acid

Indication: Common, flat juvenile & plantar warts.

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Jan 2021
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Pearl Toh, 2 days ago
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.